{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:32:08Z","timestamp":1793377928178,"version":"4.5.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.09.009","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:30:37Z","timestamp":1790220637000},"page":"5650-5651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatotoxicity in clinical gene therapy for hemophilia A: Cellular stress and the immune system"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7213-998X","authenticated-orcid":false,"given":"Roland W.","family":"Herzog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.09.009_bib1","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.ymthe.2025.03.043","article-title":"Gene therapy for hemophilia - From basic science to first approvals of \u201cone-and-done\u201d therapies","volume":"33","author":"Herzog","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.009_bib2","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.jtha.2023.10.005","article-title":"Cellular stress and coagulation factor production: when more is not necessarily better","volume":"21","author":"Chen","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2026.09.009_bib3","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2026.300542","article-title":"Biopsy-proven immune-mediated hepatitis after valoctocogene roxaparvovec","author":"La Mura","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2026.09.009_bib4","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1016\/j.ymthe.2022.07.005","article-title":"IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A mice","volume":"30","author":"Butterfield","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.009_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/hae.70261","article-title":"Treatment With Valoctocogene Roxaparvovec in a Patient With Severe Hemophilia A Led to Sustained Normal FVIII Levels","volume":"32","author":"Herbst","year":"2026","journal-title":"Haemophilia."},{"key":"10.1016\/j.ymthe.2026.09.009_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev-biochem-072909-095555","article-title":"Endoplasmic reticulum stress and type 2 diabetes","volume":"81","author":"Back","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2026.09.009_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101365","article-title":"An accomplice more than a mere victim: The impact of beta-cell ER stress on type 1 diabetes pathogenesis","volume":"54","author":"Sahin","year":"2021","journal-title":"Mol. Metab."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:35:46Z","timestamp":1793374546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525001626007793"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.009","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatotoxicity in clinical gene therapy for hemophilia A: Cellular stress and the immune system","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}